Catalyst
Slingshot members are tracking this event:
FDA rejects AstraZeneca's ZS-9 NDA -
Do you think this event is important to the companies below? How will it affect their stock price?
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 27, 2016
Related Projects
- After the CRL for ZS-9, a request of the 483s from the ZS Pharma manufacturing facilities would be good to review RLYP, AZN Executed On: Jun 07, 2016 at 03:02 PM EDT
Related Keywords
Sodium Zirconium Cyclosilicate, Zs-9 Nda, Hyperkalemia, Blood Serum, High Potassium